GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » LBT Innovations Ltd (ASX:LBT) » Definitions » Selling and Marketing Expense

LBT Innovations (ASX:LBT) Selling and Marketing Expense : A$0.10 Mil (TTM As of Dec. 2023)


View and export this data going back to 2006. Start your Free Trial

What is LBT Innovations Selling and Marketing Expense?

Selling and Marketing Expense is the aggregate total amount of expenses directly related to the marketing or selling of products or services. LBT Innovations's Selling and Marketing Expense for the six months ended in Dec. 2023 was A$0.05 Mil. Its Selling and Marketing Expense for the trailing twelve months (TTM) ended in Dec. 2023 was A$0.10 Mil.

LBT Innovations Selling and Marketing Expense Historical Data

The historical data trend for LBT Innovations's Selling and Marketing Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

LBT Innovations Selling and Marketing Expense Chart

LBT Innovations Annual Data
Trend Jun14 Jun15 Jun16 Jun17 Jun18 Jun19 Jun20 Jun21 Jun22 Jun23
Selling and Marketing Expense
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.10 - - 0.28 0.09

LBT Innovations Semi-Annual Data
Jun14 Dec14 Jun15 Dec15 Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23
Selling and Marketing Expense Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - 0.04 0.05 0.05

LBT Innovations Selling and Marketing Expense Calculation

Selling and Marketing Expense is the aggregate total amount of expenses directly related to the marketing or selling of products or services.

Selling and Marketing Expense for the trailing twelve months (TTM) ended in Dec. 2023 adds up the semi-annually data reported by the company within the most recent 12 months, which was A$0.10 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

LBT Innovations Selling and Marketing Expense Related Terms

Thank you for viewing the detailed overview of LBT Innovations's Selling and Marketing Expense provided by GuruFocus.com. Please click on the following links to see related term pages.

LBT Innovations (ASX:LBT) Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » LBT Innovations Ltd (ASX:LBT) » Definitions » Selling and Marketing Expense
Comparable Companies
ASX:CSX ASX:COV ASX:CDX ASX:AT1 ASX:OSL ASX:RSH ASX:UBI ASX:ADRDA ASX:CBL ASX:HMD ABT SYK BSX MDT XTER:SHL EW DXCM SZSE:300760 XAMS:PHIA ZBH
Traded in Other Exchanges
N/A
Address
16 Anster Street, Adelaide, SA, AUS, 5000
Website
https://www.lbtinnovations.com
LBT Innovations Ltd is a designer of advanced technology solutions for the medical industry. Its first product, MicroStreak, was a global first in the automation of the culture plate streaking process. Its second product, the Automated Plate Assessment System(APAS) is based upon LBT's intelligent imaging and machine learning software and remains the only US FDA-cleared artificial intelligence technology for automated imaging, analysis, and interpretation of microbiology culture plates following incubation.

LBT Innovations (ASX:LBT) Headlines

No Headlines